
From macroscopic clearance to molecular eradication: paradigm shift and future perspectives in the detecting of residual lesions after transurethral resection of bladder tumors.
Revolutionary advances in bladder cancer detection: molecular assessments enhance postoperative management and reduce recurrence rates. 🔬📈









